NZ212368A - Amide-containing compositions for transdermal and transmembrane penetration of topical and systemic agents - Google Patents

Amide-containing compositions for transdermal and transmembrane penetration of topical and systemic agents

Info

Publication number
NZ212368A
NZ212368A NZ212368A NZ21236885A NZ212368A NZ 212368 A NZ212368 A NZ 212368A NZ 212368 A NZ212368 A NZ 212368A NZ 21236885 A NZ21236885 A NZ 21236885A NZ 212368 A NZ212368 A NZ 212368A
Authority
NZ
New Zealand
Prior art keywords
composition
carbon atoms
hydrogen
transdermal
substance
Prior art date
Application number
NZ212368A
Other languages
English (en)
Inventor
D Mirejovsky
H Takruri
Original Assignee
Allergan Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Pharma filed Critical Allergan Pharma
Publication of NZ212368A publication Critical patent/NZ212368A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ212368A 1984-06-13 1985-06-11 Amide-containing compositions for transdermal and transmembrane penetration of topical and systemic agents NZ212368A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/620,229 US4743588A (en) 1984-06-13 1984-06-13 Compositions and methods of enhancing transdermal and transmembrane penetration systemic agents

Publications (1)

Publication Number Publication Date
NZ212368A true NZ212368A (en) 1988-03-30

Family

ID=24485099

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ212368A NZ212368A (en) 1984-06-13 1985-06-11 Amide-containing compositions for transdermal and transmembrane penetration of topical and systemic agents

Country Status (16)

Country Link
US (1) US4743588A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0164998A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS611623A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR860000065A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU582364B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1255594A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK259485A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EG (1) EG17345A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI852331A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR851421B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU193774B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL75488A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ212368A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT80625B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA854365B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZW (1) ZW9985A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837026A (en) * 1985-10-03 1989-06-06 Rajakhyaksha Vithal J Transdermal and systemic preparation and method
AU7031887A (en) * 1986-01-31 1987-08-25 Nelson Research & Development Company Compositions comprising 1-substituted azacycloalkanes and their uses
US5204339A (en) * 1986-01-31 1993-04-20 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
WO1987004594A1 (en) * 1986-01-31 1987-08-13 Nelson Research And Development Company Compositions comprising 1-substituted azacycloalkanes and their uses
EP0247900B1 (en) * 1986-05-30 1991-12-18 The Regents Of The University Of California Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease
CA1308352C (en) * 1986-08-15 1992-10-06 James V. Peck Compositions comprising 1-oxohydrocarbyl-substituted azacyclohexanes
US4917896A (en) * 1986-08-15 1990-04-17 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agents
US4808414A (en) * 1986-09-29 1989-02-28 Nelson Research & Development Co. Amide penetration enhancers for transdermal delivery of systemic agents
EP0268219A1 (en) * 1986-11-19 1988-05-25 Whitby Research Incorporated Penetration enhancers for transdermal delivery of systemic agents
EP0268218B1 (en) * 1986-11-19 1992-05-06 WHITBY RESEARCH, Inc. Penetration enhancers for transdermal delivery of systemic agents
US5112804A (en) * 1987-04-01 1992-05-12 Temple University Of The Commonwealth System Of Higher Education Pharmaceutical composition and method of intranasal administration
US4920101A (en) * 1987-09-30 1990-04-24 Nelson Research & Development Co. Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes
US4879275A (en) * 1987-09-30 1989-11-07 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agent
CA1334646C (en) * 1988-04-08 1995-03-07 James Vanolden Peck Transdermal penetration enhancers
AU3683889A (en) * 1988-06-30 1990-01-23 Upjohn Company, The Transdermal antisecretory agents for gastrointestinal disease
US5059603A (en) * 1989-06-12 1991-10-22 Centuries Laboratories, Inc. Method and composition for treating impotence
US5981591A (en) * 1992-12-04 1999-11-09 Mayor Pharmaceutical Laboratories, Inc. Sprayable analgesic composition and method of use
US6767925B1 (en) 1996-10-31 2004-07-27 Joseph A. Deihl Sprayable analgesic composition and method of use
US5980898A (en) * 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US20060002959A1 (en) * 1996-11-14 2006-01-05 Government Of The United States Skin-sctive adjuvants for transcutaneous immuization
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
US6797276B1 (en) * 1996-11-14 2004-09-28 The United States Of America As Represented By The Secretary Of The Army Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
WO1999024041A1 (en) 1997-11-10 1999-05-20 Cellegy Pharmaceuticals, Inc. Penetration enhancing and irritation reducing systems
US20040258703A1 (en) * 1997-11-14 2004-12-23 The Government Of The Us, As Represented By The Secretary Of The Army Skin-active adjuvants for transcutaneous immunization
US6262117B1 (en) 1999-02-18 2001-07-17 Allergan Sales, Inc. Method and composition for treating acne
AU4188100A (en) * 1999-04-08 2000-11-14 Gregory M. Glenn Dry formulation for transcutaneous immunization
WO2002064162A2 (en) * 2001-02-13 2002-08-22 Government Of The United States, As Represented By The Secretary Of The Army Vaccine for transcutaneous immunization
US6521613B2 (en) 2001-04-10 2003-02-18 Allergan, Inc. Lactam compounds for penetration enhancement
US20030175329A1 (en) * 2001-10-04 2003-09-18 Cellegy Pharmaceuticals, Inc. Semisolid topical hormonal compositions and methods for treatment
US20060222692A1 (en) * 2005-03-31 2006-10-05 Fairfield Clinical Trials Llc Method and compositions for transdermal administration of antimicrobial medications

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3223708A (en) * 1962-05-24 1965-12-14 Robert R Mod N-decanoyltetrahydroquinoline
US4316893A (en) * 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
DE3009546A1 (de) * 1980-03-13 1981-09-24 Henkel KGaA, 4000 Düsseldorf Desodorierende kosmetische zusammensetzungen

Also Published As

Publication number Publication date
DK259485A (da) 1985-12-14
FI852331L (fi) 1985-12-14
DK259485D0 (da) 1985-06-10
KR860000065A (ko) 1986-01-25
HU193774B (en) 1987-11-30
EP0164998A2 (en) 1985-12-18
EG17345A (en) 1991-03-30
JPS611623A (ja) 1986-01-07
ZW9985A1 (en) 1985-09-04
IL75488A (en) 1989-07-31
CA1255594A (en) 1989-06-13
EP0164998A3 (en) 1987-06-16
AU582364B2 (en) 1989-03-23
FI852331A0 (fi) 1985-06-12
PT80625A (en) 1985-07-01
HUT38543A (en) 1986-06-30
ZA854365B (en) 1986-05-28
US4743588A (en) 1988-05-10
PT80625B (en) 1987-03-26
FI852331A7 (fi) 1985-12-14
GR851421B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1985-11-25
AU4345285A (en) 1985-12-19

Similar Documents

Publication Publication Date Title
US4743588A (en) Compositions and methods of enhancing transdermal and transmembrane penetration systemic agents
AU664178B2 (en) Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers
US4837026A (en) Transdermal and systemic preparation and method
CA1306692C (en) Penetration enhancers for transdermal delivery of systemic agents
US4980378A (en) Biodegradable absorption enhancers
DE68912923T2 (de) Penetrationsfördernde oxazolidinonverbindungen.
US4808414A (en) Amide penetration enhancers for transdermal delivery of systemic agents
WO1988004938A1 (en) Heterocyclic compounds for transdermal use
US5118845A (en) Penetration enhancer for transdermal delivery of systemic agents
CA1293252C (en) Compositions comprising 1-substituted azacycloalkenes
US4886783A (en) Penetration enhancers for transdermal delivery of systemic agents
US5204339A (en) Penetration enhancers for transdermal delivery of systemic agents
US5162315A (en) Penetration enhancers
JP2782214B2 (ja) １‐オキソ‐またはチオヒドロカルビル置換アザシクロアルカンからなる組成物
EP0746294B1 (en) Absorption enhancers for topical pharmaceutical formulations
EP0036138B2 (en) Composition of matter for topical application comprising a bio-affecting agent and N,N-diethyl-m-toluamide
US5142044A (en) Penetration enhancers for transdermal delivery of systemic agents
US5270346A (en) Penetration enhancers for transdermal delivery of systemic agents
AU607951B2 (en) Penetration enhancers for transdermal delivery of systemic agents
AU603619B2 (en) Penetration enhancers for transdermal delivery of systemic agents
AU609429B2 (en) Penetration enhancers for transdermal delivery of systemic agents